Wa. Debacker et al., CENTRAL APNEA INDEX DECREASES AFTER PROLONGED TREATMENT WITH ACETAZOLAMIDE, American journal of respiratory and critical care medicine, 151(1), 1995, pp. 87-91
Citations number
30
Categorie Soggetti
Emergency Medicine & Critical Care","Respiratory System
Only a limited number of studies dealing with the epidemiology and the
rapy of central sleep apnea syndrome (CA) are available. The treatment
strategies are poorly defined and not well evaluated. The aim of our
present study was to treat selected CA patients with low dose acetazol
amide (ACET) for a longer time period than has been done before. Previ
ous studies were performed with high dose ACET provoking severe metabo
lic acidosis, not for more than 1 wk or only in obstructive apnea pati
ents. Referred patients with suspicion of sleep-related breathing diso
rders (SRBD) were included in the study if, after a first selection ni
ght, their central apnea index (CAI) was > 5 or their apnea-hypopnea i
ndex (AHI) > 10 and their obstructive apnea index (OAI) < 5. Of 327 sc
reened patients, 14(4.3%) fulfilled these criteria. Patients were then
treated with ACET (250 mg, 1 h before sleep). Polysomnography was rep
eated once after one single dose (N2) and twice after 1-mo chronic tre
atment without (N3) and with (N4) additional ACET administration. Afte
r each study night, arterial blood gases and chemical drive were measu
red. CAI (25.5 +/- 6.8 at N1) already decreased during N2(13.8 +/- 5.2
) and further during N3(6.6 +/- 2.9) and N4(6.8 +/- 2.8)(p < 0.01). OA
I remained unchanged. Total sleep time (TST) and sleep efficiency inde
x (SEI) did not change significantly. The number of arousals decreased
from 62 +/- 11 at N1 to 40 +/- 5 at N3(p = 0.019). All patients subje
ctively improved with fewer complaints of hypersomnolence, falling asl
eep during the day, memory losses, and tiredness in the morning (p < 0
.01). Pa-O2 improved from 77.0 +/- 2.7 (N1) to 91.0 +/- 2.4 mm Hg (N3)
(p < 0.01), whereas pH dropped from 7.41 +/- 0.01 (N1) to 7.38 +/- 0.
01 (N4) (p < 0.01). It is concluded that chronic therapy with low dose
ACET in patients with nonhypercapnic central sleep apnea improved the
breathing pattern and pulmonary gas exchange and reduced daytime slee
piness.